Hospital Universitario 12 de Octubre


Standort der Organisation:
Madrid, Spanien

Publikationen in Kooperation mit FAU-Wissenschaftern

Go to first page Go to previous page 1 von 2 Go to next page Go to last page
Capdevila, J., Bodei, L., Davies, P., Gorbounova, V., Jensen, R.T., Knigge, U.P.,... Wiedenmann, B. (2019). Unmet medical needs in metastatic lung and digestive neuroendocrine neoplasms. Neuroendocrinology, 108(1), 18-25.
Herrick, A.L., Peytrignet, S., Lunt, M., Pan, X., Hesselstrand, R., Mouthon, L.,... Denton, C.P. (2018). Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study. Annals of the Rheumatic Diseases.
Jaeger, V.K., Siegert, E., Hachulla, E., Airo, P., Valentini, G., Matucci-Cerinic, M.,... Walker, U.A. (2018). Racial differences in SSc disease presentation: a European scleroderma trials and research group (EUSTAR) study. (pp. 9S-9S).
Pavel, M.E., Gross, D.J., Benavent, M., Perros, P., Srirajaskanthan, R., Warner, R.R.P.,... Garcia-Carbonero, R. (2018). Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial. Endocrine-Related Cancer, 25(3), 309-322.
Van Der Zanden, L.F.M., Vermeulen, S.H., Oskarsdottir, A., Maurits, J.S.F., Diekstra, M.H.M., Ambert, V.,... Oosterwijk, E. (2017). Description of the EuroTARGET cohort: A European collaborative project on TArgeted therapy in renal cell cancer-GEnetic- and tumor-related biomarkers for response and toxicity. Urologic Oncology-Seminars and Original Investigations, 35(8), 529.e9-529.e16.
Peytrignet, S., Denton, C.P., Lunt, M., Hesselstrand, R., Mouthon, L., Silman, A.,... Herrick, A.L. (2017). Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study. Rheumatology.
Goode, E.L., Block, M.S., Kalli, K.R., Vierkant, R.A., Chen, W., Fogarty, Z.C.,... Ramus, S.J. (2017). Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer. JAMA Oncology, 3(12).
Messerli, F.H., Hofstetter, L., Agabiti-Rosei, E., Burnier, M., Elliott, W.J., Franklin, S.S.,... De Leeuw, P.W. (2017). Expertise: no longer a sine qua non for guideline authors? Journal of Hypertension, 35(8), 1564-1566.
Elhai, M., Meune, C., Boubaya, M., Avouac, J., Hachulla, E., Balbir-Gurman, A.,... Allanore, Y. (2017). Mapping and predicting mortality from systemic sclerosis. Annals of the Rheumatic Diseases.
Linz, D., Mancia, G., Mahfoud, F., Narkiewicz, K., Ruilope, L., Schlaich, M.,... Boehm, M. (2017). Renal artery denervation for treatment of patients with self-reported obstructive sleep apnea and resistant hypertension: results from the Global SYMPLICITY Registry. Journal of Hypertension, 35(1), 148-153.
Johnson, S., Soowamber, M., Fransen, J., Khanna, D., Van Den Hoogen, F., Baron, M.,... Pope, J. (2017). There is a need for new systemic sclerosis subset criteria. A content analytic approach. Scandinavian Journal of Rheumatology, 1-9.
Herrick, A.L., Pan, X., Peytrignet, S., Lunt, M., Hesselstrand, R., Mouthon, L.,... Denton, C.P. (2017). Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS). Annals of the Rheumatic Diseases.
Lopez-Isac, E., Martin, J.-E., Assassi, S., Simeon, C.P., Carreira, P., Ortego-Centeno, N.,... Martin, J. (2016). Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies. Arthritis and Rheumatology, 68(9), 2338-44.
Zanchetti, A., Liu, L., Mancia, G., Parati, G., Grassi, G., Stramba-Badiale, M.,... Ford, G. (2016). Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke. Journal of Hypertension, 34(3), 393-6.
Jaeger, V.K., Wirz, E.G., Allanore, Y., Rossbach, P., Riemekasten, G., Hachulla, E.,... Walker, U.A. (2016). Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study. PLoS ONE, 11(10), e0163894.
Lopez-Isac, E., Campillo-Davo, D., Bossini-Castillo, L., Guerra, S.G., Assassi, S., Pilar Simeon, C.,... Martin, J. (2016). Influence of TYK2 in systemic sclerosis susceptibility: a new locus in the IL-12 pathway. Annals of the Rheumatic Diseases, 75(8), 1521-6.
Schmieder, R., Bramlage, P., Haller, H., Ruilope, L.M., & Boehm, M. (2016). The Effect of Resting Heart Rate on the New Onset of Microalbuminuria in Patients With Type 2 Diabetes: A Subanalysis of the ROADMAP Study. Medicine, 95(15), e3122.
Dinges, W., Girard, P.-M., Podzamczer, D., Brockmeyer, N.H., Garcia, F., Harrer, T.,... Roman, F. (2016). The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial. Medicine, 95(6), e2673.
Mahfoud, F., Ruilope, L.M., Bohm, M., & Schmieder, R. (2015). Aldosterone antagonists and renal denervation: friends or foes? Hypertension, 65(2), 280-2.
Sandmeier, B., Jaeger, V.K., Nagy, G., Carreira, P.E., Tzankov, A., Widuchowska, M.,... Huegle, T. (2015). Autopsy versus clinical findings in patients with systemic sclerosis in a case series from patients of the EUSTAR database. Clinical and Experimental Rheumatology, 33 Suppl 9(4), 75-9.

Zuletzt aktualisiert 2016-07-06 um 12:53